Tag: immunotherapy

Moonlight Therapeutics Microneedle Patch

Company Receives $1.9 Million Grant to Advance Microneedle Patch Therapy for...

Grant will allow Moonlight Therapeutics to complete pre-clinical activities and submit and IND to the FDA.
Moonlight Therapeutics Microneedle Patch

New Microneedle Patch Therapy for Food Allergies Takes Step Forward

Painless microneedle patch may provide new method for desensitization.
Peanut SLIT

Peanut Sublingual Immunotherapy Provides Desensitization to Peanut in Toddlers

Study shows this therapy could be an option for early peanut allergy intervention.
Child Brushing Teeth

Toothpaste Therapy for Food Allergies Takes Another Step Forward

FDA accepts IND application by Intrommune Therapeutics.
Doctor Indicating Time

A Message for Food Allergy Sufferers: Now is Not the Time

Two common sense recommendations until the coronavirus crisis abates.
Aimmune + Xencor

Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development...

“In-licensing AIMab7195 demonstrates our commitment to enriching our pipeline and strengthening Aimmune’s global leadership in the evolving therapeutic landscape of food allergy treatments.”
Peanut Allergy Vaccine

Allergy Therapeutics Publishes Encouraging New Data for Peanut Allergy Vaccine Candidate

"This study indicates a paradigm shift by addressing peanut allergy via a vaccination concept instead of classic desensitisation..."
Viaskin Peanut

DBV Technologies Announces FDA Acceptance of BLA filing for Viaskin Peanut...

If approved, Viaskin Peanut would be the first and only epicutaneous immunotherapy indicated for this potentially life-threatening condition in children.
Patient Undergoing SLIT

New Peanut Allergy Treatment Passes Phase 2 Trial, Shows Effectiveness and...

UNC School of Medicine researchers show that tiny under-the-tongue doses of peanut protein can offer safe and substantial protection against peanut allergy.
FARE Reponse to ICER Report

Fare Responds to Final ICER Review of Breakthrough Peanut Allergy Therapies

FARE expresses its deep concerns with the final evidence report on two breakthrough peanut allergy therapies issued Wednesday by ICER.